CRBU
CRBU
NASDAQ · Biotechnology

Caribou Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.76
-0.01 (-0.57%)
As of Jun 30, 10:30 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +359.1% upside
Low Target $6.79
Average Target $8.08
High Target $13.52
Current Price $1.76
Current
$1.76
Target
$8.08
$6.79 $8.08 avg $13.52
Scenario Analysis
Bear Case
$6.79
285.8%
Low target
Base Case
$8.08
+359.1%
Avg target
Bull Case
$13.52
+668.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.54
-50.2% from high
52-Week Low
$1.22
+44.3% from low
Target vs 52W High
$8.08
+128.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%